Cannabis, in many ways, became a legitimate investing arena in 2018. Even so, the nascent cannabis space still has a long way to go before many of its most serious risk factors are a thing of the past. Fortunately, there are a handful of companies operating in less controversial cannabis-related areas that offer substantial growth opportunities for investors.
Hemp oil producer Medical Marijuana, Inc. (NASDAQOTH:MJNA) and cannabis consulting and professional services company MariMed Inc. (NASDAQOTH:MRMD), for example, are two under-the-radar names that both sport stellar long-term outlooks. Armed with this insight, let’s take a deeper dive to consider which of these small-cap cannabis stocks is the better buy right now.
Which stock is the better buy?
If for no other reason, MariMed’s stock is the better buy here simply because it has a far lower share count and a markedly higher share price as a result. Business prospects aside, Medical Marijuana’s ginormous share count is almost certainly going to hinder the near-term appreciation of its stock.
Read the full original article here.